Skip to contentRHOADS ANN D — QUIDEL CORP /DE/ insider: 146 transactions · InsiderLensRHOADS ANN D
- Director at NOVELLUS SYSTEMS INC · on record since May 22, 2006
- EVP, CFO, Treasurer & Sec. at ZOGENIX, INC. · on record since Nov 22, 2010
- Director at GLOBUS MEDICAL INC · on record since Aug 10, 2012
- Director at Evoke Pharma Inc · on record since Sep 26, 2013
- Director at QUIDEL CORP /DE/ · on record since May 27, 2026
- Director at IRIDEX CORP · on record since Jul 26, 2017
- Chief Financial Officer at Forty Seven, Inc. · on record since Jun 27, 2018
- Director at Repare Therapeutics Inc. · on record since Jun 25, 2020
- Director at iTeos Therapeutics, Inc. · on record since Jul 24, 2020
Insider trading activity of RHOADS ANN D
- Transactions on record
- 146
- since Apr 20, 2004
- Open-market buys
- 4
- $322K
- Open-market sells
- 9
- $3.3M
- Companies traded
- 9
- last filing Jun 29, 2026
Figures computed from official regulatory filings — methodology.
Companies where RHOADS ANN D has traded
- QUIDEL CORP /DE/57 tx · $21.2K · Jun 29, 2026
- GLOBUS MEDICAL INC30 tx · $4.8M · Jun 8, 2026
- Repare Therapeutics Inc.7 tx · $80K · Jan 28, 2026
- iTeos Therapeutics, Inc.7 tx · Aug 29, 2025
- Evoke Pharma Inc9 tx · Jul 23, 2021
- Forty Seven, Inc.8 tx · $367.1K · Apr 7, 2020
- IRIDEX CORP3 tx · Jun 15, 2018
- ZOGENIX, INC.16 tx · $329.1K · Mar 16, 2016
- NOVELLUS SYSTEMS INC9 tx · Jun 6, 2012
Track record of RHOADS ANN D
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of RHOADS ANN D
Co-insiders of RHOADS ANN D
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Biotechnology Value Trading Fund OS LPNOVELLUS SYSTEMS INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 29, 2026 | AwardD | 369 | 0.00 USD | — | SEC |
| Jun 29, 2026 | AwardD | 15,532 | 0.00 USD | — | SEC |
| Jun 29, 2026 | AwardD | 3,698 | 0.00 USD | — | SEC |
| Jun 8, 2026 | Exercise | 25,000 | 26.27 USD | $656.8K | SEC |
| Jun 8, 2026 | ExerciseD | -25,000 | 0.00 USD | $0 | SEC |
| Jun 2, 2026 | Award | 6,829 | 0.00 USD | $0 | SEC |
| Jun 2, 2026 | ExerciseD | -6,829 | 0.00 USD | $0 | SEC |
| May 27, 2026 | Award | 1,173 | 0.00 USD | $0 | SEC |
| May 27, 2026 | ExerciseD | -234 | 0.00 USD | $0 | SEC |
| May 27, 2026 | ExerciseD | -1,173 | 0.00 USD | $0 | SEC |
| May 27, 2026 | Award | 234 | 0.00 USD | $0 | SEC |
| Jan 28, 2026 | Other | -4,000 | — | — | SEC |
| Jan 23, 2026 | AwardD | 15,000 | 0.00 USD | $0 | SEC |
| Dec 10, 2025 | Buy | 750 | 28.28 USD | $21.2K | SEC |
| Nov 10, 2025 | Sell | -2,000 | 85.00 USD | $170K | SEC |
| Nov 10, 2025 | Sell | -8,000 | 81.00 USD | $648K | SEC |
| Sep 16, 2025 | Sell | -10,000 | 58.46 USD | $584.6K | SEC |
| Aug 29, 2025 | OtherD | -27,178 | — | — | SEC |
| Jun 3, 2025 | AwardD | 325 | 0.00 USD | $0 | SEC |
| Jun 3, 2025 | AwardD | 1,626 | 0.00 USD | $0 | SEC |
| Jun 3, 2025 | AwardD | 6,829 | 0.00 USD | $0 | SEC |
| Jun 2, 2025 | AwardD | 325 | 0.00 USD | $0 | SEC |
| Jun 2, 2025 | AwardD | 1,626 | 0.00 USD | $0 | SEC |
| Jun 2, 2025 | AwardD | 6,829 | 0.00 USD | $0 | SEC |
| May 28, 2025 | Award | 109 | 0.00 USD | $0 | SEC |